Final Results of a Phase 1 Study of Loncastuximab Tesirine in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.
暂无分享,去创建一个
J. Radford | K. Ardeshna | O. O’Connor | K. Havenith | J. Boni | C. Carlo-Stella | P. Caimi | M. Solh | W. Townsend | B. Kahl | M. Hamadani | D. Ungar | J. Feingold | E. Reid | L. Heffner | Luqiang Wang | Yajuan Qin | Y. Qin